JOCS
Journal of Comprehensive Surgery

The aim of the Comprehensive Surgery is to publish original research articles of the highest scientific and clinical value at the international level in all surgical fields.

eISSN: 2980-0862
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Comparison of pathologies in patients operated for transverse colon tumor with embryogenic and anatomical insights
Abstract
Aim: Transverse colon cancers account for only about 10% of all colon cancers. It is generally known that proximal and distal colon tumours have different genetic and biological features. he transverse colon serves as the division point between proximal and distal regions. In this study, transverse colon cancer was classified both embryologically and anatomically, and a comparative analysis was conducted based on pathological results. Method: A retrospective study was conducted on patients who underwent surgery for transverse colon cancer at Ankara Bilkent City Hospital between 2019 and 2023. Patients were classified embryologically as proximal and distal, and anatomically as hepatic angle, middle, and splenic angle, and pathological results were compared among these groups. Results: For embryogenic classification in terms of the final pathological staging, Group A had 1 (1.47%) in Stage 1, 32 (47.05%) in Stage 2, 26 (38.23%) in Stage 3, and 9 (13.23%) in Stage 4. Group B had 2 (2.54%) in Stage 1, 29 (50%) in Stage 2, 20 (34.48%) in Stage 3, and 7 (12.06%) in Stage 4. There was no significant difference between the groups. For anatomical classification , the number of patients in Stages 1, 2, 3, and 4 for Groups 1, 2, and 3 were as follows: Stage 1: 2 (3.5%), 1 (3.57%), 0 (0%); Stage 2: 29 (50.87%), 17 (60.81%), 15 (37.5%); Stage 3: 20 (35.7%), 7 (25%), 19 (47.5%); Stage 4: 7 (12.28%), 3 (10.71%), 6(15%).There was no statistically significant difference between the groups (p > 0.05). Conclusion: The pathological results and stages of transverse colon cancers classified embryologically and anatomically showed no significant differences among the groups.

Keywords : Colon cancer, transverse colon, embriology, anatomy

Download Article


1. Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet.2019;394(10207):1467-1480. Available from: https://pubmed.ncbi.nlm.nih.gov/31631858/
2. Venook AP, Niedzwiecki D, Innocenti F, et al. Impact of primary (1o)tumor location on overall survival (OS) and progression-free survival(PFS) in patients (pts) with metastatic colorectal cancer (mCRC):Analysis of CALGB/SWOG 80405 Alliance. 2016;34(15_suppl):3504https://doi.org/101200/JCO20163415.
3. Li C, Wang Q, Jiang KW. What is the best surgical procedure oftransverse colon cancer? an evidence map and minireview. WorldJ Gastrointest Oncol. 2021;13(5):391. Available from: /pmc/articles/PMC8131907/
4. Hohenberger W, Weber K, Matzel K, et al. Standardized surgery forcolonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Colorectal Dis. 2009;11(4):354-364.Available from: https://pubmed.ncbi.nlm.nih.gov/19016817/
5. Knol J, Keller DS. Total mesorectal excision technique-past, present,and future. Clin Colon Rectal Surg. 2020;33(3):134-143. Available from:https://pubmed.ncbi.nlm.nih.gov/32351336/
6. Heald RJ, Husband EM, Ryall RDH. The mesorectum in rectalcancer surgery—the clue to pelvic recurrence? British J Surgery.1982;69(10):613-616. doi.org/10.1002/bjs.1800691019
7. Di Buono G, Buscemi S, Cocorullo G, et al. Feasibility and safetyof laparoscopic complete mesocolic excision (CME) for right-sidedcolon cancer: short-term outcomes. a randomized clinical study. AnnSurg. 2021;274(1):57-62. Available from: https://pubmed.ncbi.nlm.nih.gov/33177355/
8. Siddiqi N, Stefan S, Jootun R, et al. Robotic complete mesocolic excision(CME) is a safe and feasible option for right colonic cancers: shortand midterm results from a single-centre experience. Surg Endosc.2021;35(12):6873-6881. Available from: https://pubmed.ncbi.nlm.nih.gov/33399993/
9. Yüksel BC, Er S, Çetinkaya E, et al. Does transverse colon cancerspread to the extramesocolic lymph node stations? Acta ChirurgicaBelgica. 2019;121(2):102-108. Available from: https://www.tandfonline.com/doi/abs/10.1080/00015458.2019.1689642
10. Lee MS, Menter DG, Kopetz S. Right versus left colon cancerbiology: integrating the consensus molecular subtypes. J NationalComprehensive Cancer Network. 2017;15(3):411-419. Available from:https://jnccn.org/view/journals/jnccn/15/3/article-p411.xml
11. Stintzing S, Tejpar S, Gibbs P, et al. Understanding the role of primarytumour localisation in colorectal cancer treatment and outcomes. Eur JCancer. 2017;84:69-80.
12. Brulé SY, Jonker DJ, Karapetis CS, et al. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefitfrom cetuximab in NCIC CO.17. Eur J Cancer. 2015;51(11):1405-1414.Available from: https://pubmed.ncbi.nlm.nih.gov/25979833/
13. Huyghe JR, Harrison TA, Bien SA, et al. Genetic architectures of proximaland distal colorectal cancer are partly distinct. Gut. 2021;70(7):1325-1334. Available from: https://pubmed.ncbi.nlm.nih.gov/33632709/
14. Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference insurvival between right- versus left-sided colon cancers? Ann SurgOncol. 2008;15(9):2388-2394. Available from: https://link.springer.com/article/10.1245/s10434-008-0015-y
15. Benedix F, Kube R, Meyer F, et al. Comparison of 17,641 patientswith right- and left-sided colon cancer: differences in epidemiology,perioperative course, histology, and survival. Dis Colon Rectum.2010;53(1):57-64.
16. Wray CM, Ziogas A, Hinojosa MW, et al. Tumor subsite location withinthe colon is prognostic for survival after colon cancer diagnosis. DisColon Rectum. 2009;52(8):1359-1366. Available from: https://journals.lww.com/dcrjournal/fulltext/2009/08000/tumor_subsite_location_within_the_colon_is.1.aspx
17. Suttie SA, Shaikh I, Mullen R, et al. Outcome of right- and left-sidedcolonic and rectal cancer following surgical resection. Colorectal Dis.2011;13(8):884-889. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1463-1318.2010.02356.x
18. Thörn M, Bergström R, Kressner U, et al. Trends in colorectal cancerincidence in Sweden 1959-93 by gender, localization, time period, andbirth cohort. Cancer Causes Control. 1998;9(2):145-152. Available from:https://pubmed.ncbi.nlm.nih.gov/9578291/
19. Stewart RJ, Stewart AW, Turnbull PRG, et al. Sex differences in subsiteincidence of large-bowel cancer. Dis Colon Rectum. 1983;26(10):658-660. Available from: https://pubmed.ncbi.nlm.nih.gov/6884156/
20. Schub R, Steinheber FU. Rightward shift of colon cancer. a feature ofthe aging gut. J Clin Gastroenterol. 1986;8(6):630-634. Available from:https://pubmed.ncbi.nlm.nih.gov/3805659/
21. Huyghe JR, Harrison TA, Bien SA, et al. Genetic architecturesof proximal and distal colorectal cancer are partly distinct. Gut.2021;70(7):1325-1334. Available from: https://pubmed.ncbi.nlm.nih.gov/33632709/
22. Lee MS, Menter DG, Kopetz S. Right versus left colon cancerbiology: integrating the consensus molecular subtypes. J NationalComprehensive Cancer Network. 2017;15(3):411-419. Available from:https://jnccn.org/view/journals/jnccn/15/3/article-p411.xml
23. Lee GH, Malietzis G, Askari A, et al. Is right-sided colon cancerdifferent to left-sided colorectal cancer? - a systematic review. EJSO.2015;41(3):300-308.
24. Wang D, Agrawal R, Zou S, et al. Gupta r. Anatomic location ofcolorectal cancer presents a new paradigm for its prognosis in AfricanAmerican patients. PLoS One. 2022;17(7):e0271629. Available from: /pmc/articles/PMC9337663/
25. Biffi R, Botteri E, Bertani E, et al. Factors predicting worse prognosisin patients affected by pT3 N0 colon cancer: long-term results of amonocentric series of 137 radically resected patients in a 5-year period.Int J Colorectal Dis. 2013;28(2):207-215. Available from: https://pubmed.ncbi.nlm.nih.gov/22903336/
26. Huh JW, Kim HR, Kim YJ. Prognostic value of perineural invasionin patients with stage II colorectal cancer. Annals Surgical Oncology.2010;17(8):2066-2072. Available from: https://link.springer.com/article/10.1245/s10434-010-0982-7
27. Pai RK, Jayachandran P, Koong AC, et al. BRAF-mutated,microsatellite-stable adenocarcinoma of the proximal colon:an aggressive adenocarcinoma with poor survival, mucinousdifferentiation, and adverse morphologic features. Am J Surg Pathol.2012;36(5):744. Available from: /pmc/articles/PMC6362986/
28. Guidelines Detail [Internet]. [cited 2023 Jul 24]. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1461
29. Guidelines Detail [Internet]. [cited 2023 Jul 24]. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1428
30. Webber AA, Gupta P, Marcello PW, et al. Lymph node retrieval coloncancer: are we making the grade? The American J Surgery. 2023;226(4):477-484. Available from: http://www.americanjournalofsurgery.com/article/S0002961023002210/fulltext
31. Huang Y, Ji L, Zhu J, et al. Lymph node status and its impact onthe prognosis of left-sided and right-sided colon cancer: A SEERpopulation-based study. Cancer Med. 2021;10(23):8708. Available from:/pmc/articles/PMC8633222/
32. Yang L, Xiong Z, Xie Q, et al. Prognostic value of total number oflymph nodes retrieved differs between left-sided colon cancer andright-sided colon cancer in stage III patients with colon cancer. BMCCancer. 2018;18(1):1-12. Available from: /pmc/articles/PMC5948673/
Article available in :
Volume 1, Issue 4, 2023
Page : 66-70
https://doi.org/10.51271/JOCS-0017
Article Information
Received : 04 Eki 2023
Accepted : 02 Kas 2023
Published : 30 Kas 2023
Corresponding Author :

Hüseyin Fahri Martlı: Department of General Surgery, Ankara Bilkent City Hospital, Ankara, Turkey

[email protected]
Citation : Şahingöz E, Göktaş A, Martlı HF, Er S, Tez M. Comparison of pathologies in patients operated for transverse colon tumor with embryogenic and anatomical insights. J Compr Surg. 2023;1(4):66-70.

Read: 286
Cited: 0
Download : 277
_Footer